In celebration of World Immunization Week, McMaster is proud to highlight our storied legacy in vaccine research, development, and innovation spanning over 50 years.
The AeroVax study will test needle-free vaccines that proved more effective than traditional injected vaccines in pre-clinical studies and the Phase 1 trial.
TB researchers Zhou Xing and Amy Gillgrass explain why they are optimistic about a future with better TB outcomes.
McMaster logo
McMaster logo
